Solubility is also important for parenteral products as well. Injectable products need to be free of particles (foreign substances and active ingredients) and often are high-concentration formulations ...

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now researchers show that a new material, ...

About 40% of marketed drugs are thought to be poorly water soluble. Development efforts might have to be redoubled, however, because between 70 and 90% of drug candidates in the pipeline are believed ...

An analysis of the approaches and tools used to tackle the problem of poorly soluble drugs. Improving the solubility of poorly water-soluble drugs is of crucial importance. As the number and diversity ...

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that ...

New partnerships with nanobiotech firms are helping pharma companies overcome solubility problems and extend profitable product lifecycles. Everybody has heard about using nanotechnology in drug ...